In late June, the FDA approved PHESGO (pertuzumab/ trastuzumab/ hyaluronidase-zzxf), a treatment that can be injected under the skin, to treat metastatic and early-stage HER2 positive breast cancer. Because it is given as an injection, PHESGO can be given by a healthcare professional in your home, and takes less time than an infusion.
Last Modified on December 12, 2023